Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BBIO | Common Stock | Award | $0 | +50K | +13.23% | $0.00 | 428K | Dec 10, 2024 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSU's have no expiration date. |
F2 | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |